A Case of Primary Hepatic Neuroendocrine Tumor and Literature Review
Related Experiment Video
Updated: Nov 11, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Pak Chiu Wong1, Wong Hoi She1, Ui Soon Khoo2
1Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
Abstract:
We report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results.

